Cargando…
The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation
Biomaterials are now being used or evaluated clinically as implants to supplement the severe shortage of available human donor organs. To date, however, such implants have mainly been developed as scaffolds to promote the regeneration of failing organs due to old age or congenital malformations. In...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016531/ https://www.ncbi.nlm.nih.gov/pubmed/27668213 http://dx.doi.org/10.3389/fbioe.2016.00071 |
_version_ | 1782452575621087232 |
---|---|
author | Griffith, May Islam, Mohammad M. Edin, Joel Papapavlou, Georgia Buznyk, Oleksiy Patra, Hirak K. |
author_facet | Griffith, May Islam, Mohammad M. Edin, Joel Papapavlou, Georgia Buznyk, Oleksiy Patra, Hirak K. |
author_sort | Griffith, May |
collection | PubMed |
description | Biomaterials are now being used or evaluated clinically as implants to supplement the severe shortage of available human donor organs. To date, however, such implants have mainly been developed as scaffolds to promote the regeneration of failing organs due to old age or congenital malformations. In the real world, however, infection or immunological issues often compromise patients. For example, bacterial and viral infections can result in uncontrolled immunopathological damage and lead to organ failure. Hence, there is a need for biomaterials and implants that not only promote regeneration but also address issues that are specific to compromised patients, such as infection and inflammation. Different strategies are needed to address the regeneration of organs that have been damaged by infection or inflammation for successful clinical translation. Therefore, the real quest is for multifunctional biomaterials with combined properties that can combat infections, modulate inflammation, and promote regeneration at the same time. These strategies will necessitate the inclusion of methodologies for management of the cellular and signaling components elicited within the local microenvironment. In the development of such biomaterials, strategies range from the inclusion of materials that have intrinsic anti-inflammatory properties, such as the synthetic lipid polymer, 2-methacryloyloxyethyl phosphorylcholine (MPC), to silver nanoparticles that have antibacterial properties, to inclusion of nano- and micro-particles in biomaterials composites that deliver active drugs. In this present review, we present examples of both kinds of materials in each group along with their pros and cons. Thus, as a promising next generation strategy to aid or replace tissue/organ transplantation, an integrated smart programmable platform is needed for regenerative medicine applications to create and/or restore normal function at the cell and tissue levels. Therefore, now it is of utmost importance to develop integrative biomaterials based on multifunctional biopolymers and nanosystem for their practical and successful clinical translation. |
format | Online Article Text |
id | pubmed-5016531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50165312016-09-23 The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation Griffith, May Islam, Mohammad M. Edin, Joel Papapavlou, Georgia Buznyk, Oleksiy Patra, Hirak K. Front Bioeng Biotechnol Bioengineering and Biotechnology Biomaterials are now being used or evaluated clinically as implants to supplement the severe shortage of available human donor organs. To date, however, such implants have mainly been developed as scaffolds to promote the regeneration of failing organs due to old age or congenital malformations. In the real world, however, infection or immunological issues often compromise patients. For example, bacterial and viral infections can result in uncontrolled immunopathological damage and lead to organ failure. Hence, there is a need for biomaterials and implants that not only promote regeneration but also address issues that are specific to compromised patients, such as infection and inflammation. Different strategies are needed to address the regeneration of organs that have been damaged by infection or inflammation for successful clinical translation. Therefore, the real quest is for multifunctional biomaterials with combined properties that can combat infections, modulate inflammation, and promote regeneration at the same time. These strategies will necessitate the inclusion of methodologies for management of the cellular and signaling components elicited within the local microenvironment. In the development of such biomaterials, strategies range from the inclusion of materials that have intrinsic anti-inflammatory properties, such as the synthetic lipid polymer, 2-methacryloyloxyethyl phosphorylcholine (MPC), to silver nanoparticles that have antibacterial properties, to inclusion of nano- and micro-particles in biomaterials composites that deliver active drugs. In this present review, we present examples of both kinds of materials in each group along with their pros and cons. Thus, as a promising next generation strategy to aid or replace tissue/organ transplantation, an integrated smart programmable platform is needed for regenerative medicine applications to create and/or restore normal function at the cell and tissue levels. Therefore, now it is of utmost importance to develop integrative biomaterials based on multifunctional biopolymers and nanosystem for their practical and successful clinical translation. Frontiers Media S.A. 2016-09-09 /pmc/articles/PMC5016531/ /pubmed/27668213 http://dx.doi.org/10.3389/fbioe.2016.00071 Text en Copyright © 2016 Griffith, Islam, Edin, Papapavlou, Buznyk and Patra. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Griffith, May Islam, Mohammad M. Edin, Joel Papapavlou, Georgia Buznyk, Oleksiy Patra, Hirak K. The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation |
title | The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation |
title_full | The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation |
title_fullStr | The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation |
title_full_unstemmed | The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation |
title_short | The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation |
title_sort | quest for anti-inflammatory and anti-infective biomaterials in clinical translation |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016531/ https://www.ncbi.nlm.nih.gov/pubmed/27668213 http://dx.doi.org/10.3389/fbioe.2016.00071 |
work_keys_str_mv | AT griffithmay thequestforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT islammohammadm thequestforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT edinjoel thequestforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT papapavlougeorgia thequestforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT buznykoleksiy thequestforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT patrahirakk thequestforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT griffithmay questforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT islammohammadm questforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT edinjoel questforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT papapavlougeorgia questforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT buznykoleksiy questforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation AT patrahirakk questforantiinflammatoryandantiinfectivebiomaterialsinclinicaltranslation |